NCT03096041View on ClinicalTrials.gov

Phase 3 Study Randomized Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors

NACompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

July 5, 2017

Primary Completion Date

July 7, 2025

Study Completion Date

July 7, 2025

Conditions
Musculoskeletal PainBreast Cancer
Interventions
DEVICE

Auriculotherapy for analgesic use

The ASP will be applied to specific pain points

DEVICE

Placebo auriculotherapy

The ASP will be applied to placebo points (not specific to pain)

Trial Locations (7)

14000

Centre François Baclesse, Caen

Unknown

Hôpital Privé Paul d'Egine, Champigny-sur-Marne

Hôpital Cognac-Jay - Forcilles, Férolles-Attilly

CHU Grenoble, Grenoble

Centre Oscar Lambret, Lille

Groupe Hospitalier Paris St Joseph, Paris

IGR, Villejuif

All Listed Sponsors
lead

Centre Francois Baclesse

OTHER

NCT03096041 - Phase 3 Study Randomized Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors | Biotech Hunter | Biotech Hunter